Partners and Exhibitors

ILCA warmly thanks all its partners and sponsors for their involvement in ILCA 2018

Diamond Partner

Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise at Bayer currently includes four oncology products in eight indications. Several other compounds are in various stages of clinical development, with the focus on potential first-in-class approaches across the areas of novel oncogenic signaling in combination with an effective biomarker strategy, antibody drug conjugates including a thorium platform and immuno-oncology. An Oncology Strategic Business Unit within the Pharmaceuticals Division of Bayer was established in 2017 to support the accelerated development of new treatment options.
July 2018 | UKBAY06180285

Platinum Partner

At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business
with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer’s disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US.

Silver Partners

BTG is a global healthcare company focused on Interventional Medicine. Our growing portfolio is designed to advance the treatment of cancer, vascular conidtions and severe emphysema. No company does more to help doctors in their quest to see more, reach further and treat smarter. btg-im.com
Sirtex Medical is an Australian based medical device company with global market coverage. Its innovative core technology is a selective internal radiation therapy (SIRT) with SIR-Spheres Y-90 resin microspheres for unresectable liver tumours with over 86,000 doses supplied and administered at over 1,160 medical centres in more than 40 countries.

BTG is a global healthcare company focused on Interventional Medicine. Our growing portfolio is designed to advance the treatment of cancer, vascular conditions and severe emphysema. No company does more to help doctors in their quest to see more, reach further and treat smarter. btg-im.com

Sirtex Medical is an Australian based medical device company with global market coverage. Its innovative core technology is a selective internal radiation therapy (SIRT) with SIR-Spheres Y-90 resin microspheres for unresectable liver tumours with over 86,000 doses supplied and administered at over 1,160 medical centres in more than 40 countries. www.sirtex.com

Exhibitors and Other Partners

Incyte
IPSEN

Media Partners